Evaluation of phenylpiperazines as targeting agents for neuroblastoma
1996

Using Phenylpiperazines to Target Neuroblastoma

Sample size: 30 publication Evidence: moderate

Author Information

Author(s): JW Babich, WA Graham, AJ Fischman

Primary Institution: Massachusetts General Hospital and Harvard Medical School

Hypothesis

Can phenylpiperazine derivatives effectively inhibit MIBG uptake in neuroblastoma cells?

Conclusion

Phenylpiperazines show significant affinity for neuroblastoma and have uptake and retention characteristics similar to MIBG.

Supporting Evidence

  • Phenylpiperazines inhibited MIBG uptake in neuroblastoma cells.
  • The IC50 values for inhibition of MIBG uptake were determined for various phenylpiperazines.
  • Biodistribution studies showed that phenylpiperazines have a distribution pattern similar to MIBG.
  • Statistical analysis confirmed significant differences in uptake between compounds.

Takeaway

This study looked at how certain chemicals can help find and treat a type of cancer called neuroblastoma by blocking a specific process in the cancer cells.

Methodology

In vitro pharmacological studies with human neuroblastoma cell lines and in vivo biodistribution measurements in rats.

Limitations

The study may not fully account for the long-term effects of phenylpiperazines in vivo.

Participant Demographics

Normal male Sprague-Dawley rats weighing approximately 150 g.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication